Altay Regional Oncology Dispensary

Barnaul 656049

0 studies enrolling now · 4 studies all time

What they study most

Endometrial Neoplasms, Hepatocellular Carcinoma, Non-Hodgkin's Lymphoma, Prostate Cancer Metastatic

Studies at this site

• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — Completed
• A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma — Completed
• EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer — Completed
• Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma — Completed